BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND MEN1, ENSG00000133895, 4221
1747 results:

  • 1. Combined deletion of men1, ATRX and PTEN triggers development of high-grade pancreatic neuroendocrine tumors in mice.
    Fuentes ME; Lu X; Flores NM; Hausmann S; Mazur PK
    Sci Rep; 2024 Apr; 14(1):8510. PubMed ID: 38609433
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Gastric neuroendocrine neoplasms.
    Lamberti G; Panzuto F; Pavel M; O'Toole D; Ambrosini V; Falconi M; Garcia-Carbonero R; Riechelmann RP; Rindi G; Campana D
    Nat Rev Dis Primers; 2024 Apr; 10(1):25. PubMed ID: 38605021
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The lesion detection rate of Ga-68 DOTATATE PET/MR in multiple endocrine neoplasia type 1.
    Gao J; Liu C; Zhou J; Pan Y; Zhang Y
    J Med Imaging Radiat Oncol; 2024 Apr; 68(3):250-256. PubMed ID: 38563291
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genetic disorders and insulinoma/glucagonoma.
    Marini F; Giusti F; Brandi ML
    Endocr Relat Cancer; 2024 May; 31(5):. PubMed ID: 38552306
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Multiregion WES of metastatic pancreatic neuroendocrine tumors revealed heterogeneity in genomic alterations, immune microenvironment and evolutionary patterns.
    Jiang Y; Dong YH; Zhao SW; Liu DY; Zhang JY; Xu XY; Chen H; Chen H; Jin JB
    Cell Commun Signal; 2024 Mar; 22(1):164. PubMed ID: 38448900
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Comparative analysis of bone complications/manifestations in sporadic and men1-related primary hyperparathyroidism].
    Pylina SV; Eremkina AK; Elfimova AR; Gorbacheva AM; Mokrysheva NG
    Probl Endokrinol (Mosk); 2024 Feb; 70(1):81-90. PubMed ID: 38433544
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Updates on the genetics of multiple endocrine neoplasia.
    Sahakian N; Castinetti F; Romanet P; Reznik Y; Brue T
    Ann Endocrinol (Paris); 2024 Apr; 85(2):127-135. PubMed ID: 38325596
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Microwave ablation for recurrent primary hyperparathyroidism in four patients with multiple endocrine neoplasia type 1: a case series report.
    Tan J; Zhang Y; Han X; Fan Y; Xu J; Chen G; Liu C; Xu S
    Int J Hyperthermia; 2024; 41(1):2308056. PubMed ID: 38314667
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Plasma miRNA expression in patients with genetically confirmed multiple endocrine neoplasia type 1 syndrome and its phenocopies].
    Trukhina DA; Mamedova EO; Nikitin AG; Koshkin PA; Belaya ZE; Melnichenko GA
    Probl Endokrinol (Mosk); 2024 Jan; 69(6):70-85. PubMed ID: 38311997
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Intraoperative segmental pancreatic occlusion and insulin assay combination optimizes the localization of lesions and confirmation of complete resection in pancreatic hypoglycemia patients.
    Atyah MM; Huang J; Yang Z
    Surgery; 2024 Apr; 175(4):1147-1153. PubMed ID: 38267341
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Whole-Exome Screening and Analysis of Signaling Pathways in Multiple endocrine Neoplasia Type 1 Patients with Different Outcomes: Insights into Cellular Mechanisms and Possible Functional Implications.
    Skalniak A; Trofimiuk-Müldner M; Surmiak M; Totoń-Żurańska J; Jabrocka-Hybel A; Hubalewska-Dydejczyk A
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256138
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical utility of plasma cell-free DNA in pancreatic neuroendocrine neoplasms.
    Cowzer D; Shah RH; Chou JF; Kundra R; Punn S; Fiedler L; DeMore A; Capanu M; Berger MF; Reidy-Lagunes D; Raj N
    Endocr Relat Cancer; 2024 Apr; 31(4):. PubMed ID: 38252063
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Spatial profiling reveals tissue-specific neuro-immune interactions in gastroenteropancreatic neuroendocrine tumors.
    Duan S; Sawyer TW; Witten BL; Song H; Else T; Merchant JL
    J Pathol; 2024 Mar; 262(3):362-376. PubMed ID: 38229586
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Individualized approach for men1-associated duodenopancreatic neuroendocrine neoplasms].
    Manoharan J; Albers MB; Bartsch DK
    Chirurgie (Heidelb); 2024 Mar; 95(3):207-215. PubMed ID: 38180518
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Multiple neuroendocrine tumors of the pancreas].
    Sipos B
    Pathologie (Heidelb); 2024 Feb; 45(1):28-34. PubMed ID: 38180510
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. endocrine tumors of the female reproductive tract.
    Asa SL; Ezzat S
    Mol Cell Endocrinol; 2024 Mar; 582():112123. PubMed ID: 38135144
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Recurrent Primary Hyperparathyroidism in Multiple endocrine Neoplasia Type 1 Syndrome.
    Libánský P; Čarková J; Kushnir I; Matějková Běhanová M; Procyklová K; Šedý J; Vaculová M; Včelák J; Zikán V; Adámek S
    Physiol Res; 2023 Dec; 72(S4):S423-S427. PubMed ID: 38116778
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Beyond the three P's: adrenal involvement in men1.
    Clemente-Gutierrez U; Pieterman CRC; Lui MS; Yamashita TS; Tame-Elorduy A; Huang BL; Shirali AS; Erstad DJ; Lee JE; Fisher SB; Graham PH; Grubbs EG; Waguespack SG; Ng CS; Perrier N
    Endocr Relat Cancer; 2024 Feb; 31(2):. PubMed ID: 38108666
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Management of Gastric Neuroendocrine Tumors: A Review.
    Sok C; Ajay PS; Tsagkalidis V; Kooby DA; Shah MM
    Ann Surg Oncol; 2024 Mar; 31(3):1509-1518. PubMed ID: 38062290
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Genetic Testing in Hereditary Pituitary Tumors.
    Akkuş G; Korbonits M
    Arch Med Res; 2023 Dec; 54(8):102920. PubMed ID: 38007383
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 88.